Director, Clinical Laboratory

Foster City, California, United States

Auto‑apply with AI Apply

$180,000 – $220,000Compensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Medical Devices, GenomicsIndustries

Requirements

Candidates must hold a Doctor of Medicine (MD) or Doctor of Osteopathic Medicine (DO) degree and be board-certified. Prior experience serving as a CLIA Director or Section Director with a successful record in laboratory operations, test development, bioinformatics, quality, and customer service is required. Experience in somatic oncology molecular testing is strongly preferred.

Responsibilities

The Director, Clinical Laboratory will provide interpretation of special test results, including solid tumor comprehensive genomic profiling and genetic testing. They will perform microscopic examinations for tumor area selection, interpret molecular diagnostic reports with variant curation and analysis, consult with ordering physicians, collaborate with cross-functional teams on new product launches, support validation studies, ensure CLIA and CAP compliance, and keep current with medical knowledge related to genetics and oncology.

Skills

Molecular Diagnostics

Genetic Testing

Variant Curation

Bioinformatics

CLIA Compliance

CAP Compliance

Solid Tumor Comprehensive Genomic Profiling

Microscopic Examination

Tumor Area Selection

Medical Knowledge (Genetics & Oncology)

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters

1998Year Founded

$27.2MTotal Funding

IPOCompany Stage

Venture Capital, BiotechnologyIndustries

5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.

Standardizing proteomics data across platforms could challenge Illumina's data reliability.

Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.

The company offers innovative array-based solutions for DNA, RNA, and protein analysis.

Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.

Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.

Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI

Try Jobo Free